Oxford Nanopore Technologies Ltd. is seeking a Field Applications Scientist, Bioinformatics, to partner closely with our Sales team and customers. You’ll provide pre- and post-sales technical expertise across our sequencing platforms and software—helping researchers design experiments, analyze data, and achieve successful outcomes while strengthening long-term relationships.
This is a field-based role supporting customers across New York and New Jersey. Candidates should reside within the territory, ideally within reasonable proximity to the New York City metropolitan area to support frequent customer engagement and regional travel.
The role requires frequent local customer visits and occasional overnight travel, up to approximately 40%, and may include technical support for adjacent territories as business needs require.
Partner with Sales to deliver high-quality technical consultations across the sales cycle; provide back-up technical support to adjacent territories. Deliver technical presentations, seminars, trainings, and on-site engagements at key accounts and scientific conferences. Guide customers on experimental design, software usage, analysis workflows, and best practices for ONT technologies. Manage key customer relationships from a technical perspective to ensure successful adoption and outcomes. Document and track customer interactions, inquiries, and actions in the CRM.
Monitor competitive technologies and market trends; share actionable insights with commercial and product teams.
Field-based role with frequent local customer visits and occasional overnight travel (up to ~40%)
The salary for this role is between $97,479 and $121,849. The salary offered will reflect the skills and experience of the candidate. Certain roles within ONT are eligible for annual bonus and stock. These awards are allocated based on individual performance. Employees based in the US have the option to choose healthcare benefits, participate in the company 401(k) plan and company match, we also offer short-term and long-term disability coverage, basic life insurance, and commuter benefits to name a few.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
